FSFanghui Shi

Fanghui Shi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fanghui Shi has a total of 44 co-authors. Here are the top co-authors by number of shared publications:

  • Xiaoming Li

    South Carolina SmartState Center for Healthcare Quality, University of South Carolina Arnold School of Public Health, Columbia, SC 29208, United States

    20 shared publications
  • Sharon Weissman

    South Carolina SmartState Center for Healthcare Quality, University of South Carolina Arnold School of Public Health, Columbia, SC 29208, United States

    18 shared publications
  • Xueying Yang

    Department of Health Promotion, Education and Behavior, Arnold School of Public Health, University of South Carolina, Columbia, SC, 29208, USA

    18 shared publications
  • Jiajia Zhang

    Arnold School of Public Health, South Carolina SmartState Center for Healthcare Quality, University of South Carolina, Columbia, USA

    14 shared publications
  • Bankole Olatosi

    South Carolina SmartState Center for Healthcare Quality, University of South Carolina, Arnold School of Public Health, Columbia, SC

    9 shared publications
  • Bankole Olatosi

    Arnold School of Public Health, South Carolina SmartState Center for Healthcare Quality, University of South Carolina, Columbia, USA

    7 shared publications

Latest Publications

  • Open Access

    Computational phenotyping of sexually transmitted infections with the All of Us Research Program from 2010 to 2023

    by Fanghui Shi, Huiyi Xia, Sharon Weissman, Xiaoming Li, Xueying Yang

    This study aims to develop comprehensive computable phenotyping algorithms that integrate multiple domains of electronic health record (EHR) data within the All of Us (AoU) Researcher Workbench to identify sexually transmitted infection (STI) cases and characterize STI patterns. We used AoU controlled tier data, version 8, which included participants enrolled from May 6, 2018, to October 1, 2023. Using data across multiple domains of EHRs in AoU, such as diagnostic codes, laboratory results, and medication records, we developed computational phenotyping algorithms to identify 3 leading STIs: chlamydia, gonorrhea, and syphilis. Among 393 596 participants with EHR data in AoU, 2603 had confirmed chlamydia, 1520 had gonorrhea, and 2762 had syphilis. By utilizing information from diagnostic codes and medication records, we identified an additional 4843 individuals with possible/presumed chlamydia and 18 855 individuals with possible/presumed gonorrhea. Among 5784 participants with at least one confirmed STI, 115 (2.0%) had all 3 infections. A notable shift in STI trends occurred in 2019, with the occurrence increasing from 2010 to 2019 before declining through 2023 across different STIs. The comprehensive computable phenotype algorithms developed in this study provide an enhanced approach to identifying STI cases that may be missed using traditional lab-based methods. The computable phenotypes developed in this study provide a practical framework for more nuanced STI classification and downstream analysis in All of Us. Our approach may also support clinical and public health efforts by improving case identification beyond laboratory-only methods and informing interventions addressing clinical and social needs.

  • Open Access

    Racial Disparities and Social Determinants of Long COVID in the United States: Evidence from the 2022 Behavioral Risk Factor Surveillance System

    by Sarah Pence, Yiding Zhuang, Fanghui Shi, Xueying Yang

    Background: While racial disparities in COVID-19-related outcomes and the role of social determinants of health (SDOH) are well documented, few studies have examined how race/ethnicity and SDOH jointly influence the occurrence of long COVID (LC) and the variation in its primary symptoms. Methods: Using 2022 Behavioral Risk Factor Surveillance System data, we estimated LC prevalence across racial/ethnic groups and calculated a SDOH summary score (0–10), with higher scores indicating greater exposure to adverse SDOH. Logistic regressions were employed to assess associations of SDOH and race/ethnicity with the presence of LC and primary LC symptoms. Adjusted average marginal effects (AMEs) were calculated to quantify differences in LC prevalence across SDOH levels and racial/ethnic groups. Results: Among 92,109 respondents who tested positive for COVID-19, 20,393 (22.14%) reported experiencing LC. Compared to non-Hispanic Whites, non-Hispanic Black (adjusted odds ratio [aOR] = 0.82, 95% confidence interval [CI]: 0.668–0.999) and Asian (aOR = 0.58, 95% CI:0.370.89) individuals were less likely to report LC. Higher SDOH scores were associated with increased LC risk, with aOR (95%CI) being 1.47(1.28–1.69), 1.56(1.29–1.87), 2.26(1.80–2.83), and 3.21(2.65–3.89) for scores of 1, 2, 3, and ≥ 4, respectively, compared with a score of 0. Compared to White individuals, Black and Hispanic respondents had higher odds of reporting joint/muscle pain (aOR = 3.03, 95%CI: 1.49–6.18, and OR = 3.11, 95%CI: 1.84–5.25, respectively). Higher SDOH scores were linked to increased risk of joint/muscle pain, dizziness, and post-exertional symptoms, but decreased risk of taste/smell loss. Conclusion: Greater SDOH burden was associated with higher LC prevalence and variation in primary symptoms, with effects differing across racial/ethnic groups. These findings highlight the importance of addressing social conditions in efforts to reduce LC disparities.

  • Long COVID Between People With and Without HIV: A Statewide Cohort Analysis

    by Fanghui Shi, Huiyi Xia, Xiaoming Li, Bankole Olatosi, Sharon Weissman, Xueying Yang

    Background: This study aimed to compare the risks of a panel of long COVID (LC) manifestations between people with HIV (PWH) and people without HIV (PWoH). Methods: Using integrated statewide electronic health record data from the HIV cohort and COVID-19 tester cohort, we identified COVID-19–positive individuals by HIV status between March 02, 2020, and January 15, 2022, in South Carolina. A total of 13 diagnosis groups encompassing 131 potential LC categories were identified. We used inverse probability weighting based on propensity scores to balance covariates between the PWH and PWoH, including age, sex, race, and vaccination status. Cox Proportional Hazard regression models were used to estimate the risk of each diagnosis group examined. Results: Among a total of 838,520 COVID-19–positive individuals, 2662 were with HIV and 835,858 were without HIV. The prevalence of any LC diagnosis was 16.3% and 10.6% for PWH and PWoH, respectively. Compared with PWoH, PWH were found to be at a higher risk of at least one of the LC diagnosis groups (hazard ratio [HR] = 1.29, 95% confidence interval [95% CI]: 1.09 to 1.54) and the highest risk was for diseases of the nervous system (HR = 2.04, 95% CI: 1.42 to 2.92), followed by mental disorders (HR = 1.78, 95% CI: 1.12 to 2.82) and respiratory system (HR = 1.78, 95% CI: 1.18 to 2.69). Conclusions: Our study highlights the consistent and elevated LC burden in PWH, emphasizing the importance of sustained follow-up for COVID-19 survivors to improve their clinical outcomes and prevent morbidity of LC.


  • Open Access

    Healthcare Transition From Pediatric to Adult Care Among Youth Living With HIV in South Carolina: Retrospective Study From 2005 to 2021

    by Fanghui Shi, Huiyi Xia, Katherine E. Weaver, Xiaoming Li, Bankole Olatosi, Sharon Weissman, Rebecca Widener, Xueying Yang

  • Open Access

    Examining Faith-Based HIV Prevention Interventions in the United States: A Scoping Review

    by Sarah Grace Frary, Fanghui Shi, Shan Qiao, Sayward Harrison

    Faith-based health promotion is a promising approach for delivering tailored and culturally salient HIV prevention programs in the United States. However, since approval of pre-exposure prophylaxis (PrEP) in 2012, no review of faith-based HIV prevention interventions has been published in the peer-reviewed literature. This review aims to synthesize literature describing HIV prevention interventions housed in faith communities in the US, with a focus on examining inclusion of PrEP-related content. Synthesis of literature was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis scoping review extension. Databases reviewed included PubMed, Sociological Abstracts, PsycINFO, and Cumulative Index of Nursing. Two independent reviewers screened studies, determined inclusion, and extracted relevant data based on the Reach, Effectiveness, Adoption, Implementation, Maintenance framework for intervention planning/evaluation. In total, 16 studies met inclusion criteria and were included in the review. All identified faith-based HIV prevention interventions were implemented by Christian organizations. Interventions primarily focused on abstinence, reducing substance use, reducing stigma, and promoting HIV testing. Very few included studies had meaningful content related to PrEP. Partnerships with faith communities often involved interventions being designed, housed, and evaluated within their specific religious organizations. This review discusses the significance and challenges of implementing HIV prevention interventions in partnership with faith communities and highlights existing gaps in faith-based PrEP promotion programming in the US. Findings show opportunities to broaden involvement of diverse faith organizations in HIV prevention intervention efforts and to scale up inclusion of PrEP-focused education and services.

  • Open Access

    Factors associated with lapses in care among people living with HIV in South Carolina

    by Xueying Yang, Fanghui Shi, Shujie Chen, Gavi Samuel, Bankole Olatosi, Sharon Weissmen, Xiaoming Li, Jiajia Zhang

    Utilizing statewide electronic health records (EHR) data, this study aims to assess the factors determining the occurrence of lapses in HIV care among people with HIV (PWH) in South Carolina (SC). All adult (≥ 18 years old) PWH who were diagnosed with HIV between 2006 and 2018 with at least two HIV care encounters and at least 1-year follow-up record were included in the analysis. The outcome, a lapse in care, was defined as a repeated measure of HIV care encounter that occurs over a year following the previous visit. Generalized Estimation Equation models were employed. The study cohort had 8,856 PWH, of which 3,888 (43.9%) had a lapse in HIV care, and 1,405 (36.14%) PWH had multiple lapses. Background characteristics, such as longer duration of HIV diagnosis, being male, and being infected with HIV through injecting drug use or men who have sex with men were associated with a higher risk of a lapse in care. A variety of comorbidities, such as cardiovascular disease, liver disease, and renal disease, were associated with lower odds of a lapse in HIV care.

  • Open Access

    Dyadic Internalized Stigma, Resilience, and Psychological Distress Among People with HIV and their Family Members: An Actor-Partner Interdependence Mediation Model Analysis

    by Fanghui Shi, Xueying Yang, Shan Qiao, Cheuk Chi Tam, Shuaifeng Liu, Yuejiao Zhou, Xiaoming Li

    Despite robust evidence showing the mediation role of psychological resilience in the impacts of HIV-related stigma on psychological distress, most studies were conducted from an intrapersonal perspective. Limited studies have examined the dyadic effects of HIV-related stigma and resilience on psychological distress for people with HIV (PWH) and their family members. This study aimed to explore the actor-partner effect and the mediation role of resilience in the relationship between internalized stigma and psychological distress among PWH and family members dyads. Between October 2023 and December 2023, a total of 800 PWH-family member dyads were recruited from two urban cities and nine rural counties in Guangxi, China. All participants completed validated questionnaires capturing demographic characteristics, internalized stigma, resilience, and psychological distress. This study employed the actor-partner interdependence mediation model to examine both individual (actor) and dyadic (partner) pathways, along with resilience as a mediator. For actor effects, resilience partially mediated the relationship between internalized stigma and psychological distress in PWH (β = 0.08, SE = 0.01, p < 0.001) but not in their family members (β = -0.00, SE = 0.01, p = 0.68). Regarding partner effects, indirect effects were significant in the association between family members’ internalized stigma and PWH’s psychological distress through PWH’s resilience (β = 0.03, SE = 0.01, p < 0.01). This study underscores the complex interplay between internalized stigma, resilience, and psychological distress in PWH-family member dyads. Psychological health promotion programs would benefit from adopting family-centered strategies that attend to stigma reduction and resilience improvement for both PWH and family members.


  • Open Access

    Family Relationships, Resilience, and Quality of Life in People Living with HIV and Their Family Members: An Actor-Partner Interdependence Mediation Model

    by Cuihong Huang, Fanghui Shi, Xueying Yang, Shuaifeng Liu, Yuejiao Zhou, Xiaoming Li

    Objectives: To explore the association between family relationships and quality of life (QoL), and the mediating role of resilience among people living with HIV (PLWH) and their family members (FMs). Methods: Baseline data were drawn from an ongoing study in Guangxi, China, including 783 PLWH-FM dyads. The actor-partner interdependence mediation model examined how individuals’ family relationships/cohesion affect their own (actor effects) and their partners’ QoL (partner effects), and the mediating role of resilience. Results: A significant actor-direct effect was observed for FMs’ family relationships on their own mental QoL ( β = 0.136, P < 0.001), while no such effect was found for PLWH. Resilience functioned as a mediator between PLWH's family cohesion and PLWH's QoL (physical: β = 0.109, mental: β = 0.089, P < 0.001) and between FMs’ family relationships and FMs’ QoL (physical: β = 0.062, mental: β = 0.075, P < 0.001). Regarding partner effects, FMs’ resilience mediated the association between PLWH's family cohesion and FMs’ QoL (physical: β = 0.036, mental: β = 0.044, P < 0.01). Conclusion: Findings underscore that future interventions should target the family as a unit to strengthen family ties and improve the cross-dyadic role of resilience, particularly that of FMs.

  • Open Access

    Sex differences in cardiovascular disease and associated factors in people living with HIV : Evidence from All of Us program

    by Hao Zhang, Huiyi Xia, Fanghui Shi, Qingyang Li, Sharon Weissman, Xiaoming Li, Xueying Yang

    Background: People living with HIV (PLWH) face a higher risk of cardiovascular disease (CVD), with significant sex differences in outcomes. However, it is unclear whether these differences are driven by distinct risk factor profiles or by a differential impact of shared risk factors. This study aimed to identify factors associated with CVD among PLWH and to specifically assess for effect modification by sex using a large, diverse nationwide database. Methods: We utilized data from the All of Us Research Program (AoU). The primary outcome was a composite of coronary artery disease or stroke. We used multivariable logistic regression to identify factors associated with CVD in the overall cohort. To assess for effect modification, we introduced interaction terms between sex and key covariates. Subsequently, sex‐stratified analyses were performed to explore these differences. Results: Among 6464 PLWH (4608 men and 1856 women), women had a higher prevalence of CVD than men (24.8% vs. 21.9%, p = 0.011). We identified significant interaction effects between sex and several key risk factors, including hypertension, unemployment and hyperlipidaemia ( p < 0.05 for all). In stratified analyses comparing women to men within these risk groups, the association of hypertension with CVD was substantially stronger in women than in men (adjusted odds ratio [aOR] = 4.928, 95% CI: 2.827–8.586). Similarly, the effects of unemployment and hyperlipidaemia on CVD were more pronounced in women. In fully stratified models, a detectable viral load was a significant risk factor for CVD only among men (aOR = 1.524, 95% CI: 1.130–2.049). Conclusions: While many traditional and HIV‐specific CVD risk factors are shared between men and women living with HIV (WLWH), our findings reveal that the magnitude of their effect is not uniform. The impact of key risk factors, particularly hypertension, is substantially greater in women, suggesting a heightened vulnerability to these exposures. These findings underscore the critical need for sex‐specific risk assessments and aggressively tailored prevention strategies for PLWH.


  • Open Access

    Tenofovir alafenamide fumarate use for HIV pre-exposure prophylaxis and weight gain

    by Fanghui Shi, Huiyi Xia, Sharon Weissman, Xiaoming Li, Xueying Yang

    Daily oral pre-exposure prophylaxis (PrEP), including emtricitabine/tenofovir disoproxil fumarate (TDF) and emtricitabine/tenofovir alafenamide fumarate (TAF), is a key strategy for HIV prevention. Compared to TDF-based PrEP, TAF may be associated with greater weight gain. This study aims to examine the risk of weight gain among cisgender men and transgender women who were adults and took TAF for HIV prevention using real-world data. This study used data from All of Us, a nationwide research initiative designed to accelerate health and medical discoveries. All PrEP users in All of Us with at least two weight measures, one taken within 180 days prior to and the other between 90 and 365 days after initiating PrEP, were included in analyses. Linear regression was conducted to explore the association between different PrEP regimens and weight gain, adjusting for key sociodemographic characteristics. Among 385 eligible individuals, 284 were TDF-only users, 52 were TAF-only users, and 49 individuals switched from TDF to TAF. The median follow-up time for participants was 312 days. The average weight gain (in kilograms) for TDF-only, TAF-only, and TDF-TAD groups was − 0.68 (standard deviation [SD] = 5.43), 1.80 (SD = 11.60), and 1.74 (SD = 6.35), respectively. TAF-only (β = 2.532, 95%CI 0.708–4.356) and TDF-TAF (β = 2.756, 95%CI 0.890–4.621) were associated with significantly increased weight gain compared to TDF-only use. Closer monitoring of weight gain is recommended for individuals using TAF to prevent HIV.